Drug
Brimonidine Tartrate Ophthalmic
Brimonidine Tartrate Ophthalmic: highest development phase Phase 3, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Brimonidine Tartrate Ophthalmic Suspension NCT03450629 | Phase 3 | Open Angle Glaucoma |
Latest
No recent events.
Follow Brimonidine Tartrate Ophthalmic on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.